Show simple item record

Authordc.contributor.authorLangendam, Miranda 
Authordc.contributor.authorCarrasco Labra, Alonso 
Authordc.contributor.authorSantesso, Nancy 
Authordc.contributor.authorMustafa, Reem 
Authordc.contributor.authorBrignardello Petersen, Romina 
Authordc.contributor.authorVentresca, Matthew 
Authordc.contributor.authorHeus, Pauline 
Authordc.contributor.authorLasserson, Toby 
Authordc.contributor.authorMoustgaard, Rasmus 
Authordc.contributor.authorBrozek, Jan 
Authordc.contributor.authorSchunemann, Holger 
Admission datedc.date.accessioned2016-12-06T18:57:08Z
Available datedc.date.available2016-12-06T18:57:08Z
Publication datedc.date.issued2016
Cita de ítemdc.identifier.citationJournal of Clinical Epidemiology 74 (2016) 19-27es_ES
Identifierdc.identifier.other10.1016/j.jclinepi.2015.12.008
Identifierdc.identifier.urihttps://repositorio.uchile.cl/handle/2250/141693
Abstractdc.description.abstractObjectives: The Grading of Recommendations Assessment, Development, and Evaluation (GRADE) working group has developed GRADE evidence profiles (EP) and summary of findings (SoF) tables to present evidence summaries in systematic reviews, clinical guidelines, and health technology assessments. Explanatory notes are used to explain choices and judgments in these summaries, for example, on rating of the quality of evidence. Study Design and Setting: A systematic survey of the explanations in SoF tables in 132 randomly selected Cochrane Intervention reviews and in EPs of 10 guidelines. We analyzed the content of 1,291 explanations using a predefined list of criteria. Results: Most explanations were used to describe or communicate results and to explain downgrading of the quality of evidence, in particular for risk of bias and imprecision. Addressing the source of baseline risk (observational data or control group risk) was often missing. For judgments about downgrading the quality of evidence, the percentage of informative explanations ranged between 41% (imprecision) and 79% (indirectness). Conclusion: We found that by and large explanations were informative but detected several areas for improvement (e.g., source of baseline risk and judgments on imprecision). Guidance about explanatory footnotes and comments will be provided in the last article in this series. (C) 2016 Elsevier Inc. All rights reservedes_ES
Patrocinadordc.description.sponsorshipCochrane Collaboration's Methods Innovation Fund McMaster GRADE Centeres_ES
Lenguagedc.language.isoenes_ES
Publisherdc.publisherElsevieres_ES
Type of licensedc.rightsAttribution-NonCommercial-NoDerivs 3.0 Chile*
Link to Licensedc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/cl/*
Sourcedc.sourceJournal of Clinical Epidemiologyes_ES
Keywordsdc.subjectGRADEes_ES
Keywordsdc.subjectQuality of evidencees_ES
Keywordsdc.subjectSystematic reviewses_ES
Keywordsdc.subjectHealth technology assessmentes_ES
Keywordsdc.subjectRisk of biases_ES
Keywordsdc.subjectSummary of findings tableses_ES
Keywordsdc.subjectGRADEproes_ES
Títulodc.titleImproving GRADE evidence tables part 2: a systematic survey of explanatory notes shows more guidance is neededes_ES
Document typedc.typeArtículo de revista
Catalogueruchile.catalogadorapces_ES
Indexationuchile.indexArtículo de publicación ISIes_ES


Files in this item

Icon

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivs 3.0 Chile
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs 3.0 Chile